Cyclin D1 amplification and pl6(MTS1/CDK4I) deletion correlate with poor prognosis in head and neck tumors

Laryngoscope

Volumn 112, Issue 3, 2002, Pages 472-481

  Namazie, Ali ^a   Alavi, Sassan ^a   Olopade, Olufunmilayo I ^d   Pauletti, Giovanni ^b   Aghamohammadi, Neema ^a   Aghamohammadi, M ^a   Gornbein, Jeffrey A ^b   Calcaterra, Thomas C ^a   Slamon, Dennis J ^b   Wang, Marilene B ^a,c   Srivatsan, Eri S ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

^d UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

Author keywords

Cyclin D1; Fluorescence in situ hybridization; Head and neck tumors; p16

Indexed keywords

CYCLIN D1; CYCLIN DEPENDENT KINASE 4; PROTEIN P16;

ADULT; AGED; ARTICLE; CHROMOSOME 11Q; CHROMOSOME 9P; CONTROLLED STUDY; CORRELATION FUNCTION; ENZYME ACTIVITY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; FLUORESCENCE MICROSCOPY; GENE AMPLIFICATION; GENE DELETION; HEAD AND NECK CANCER; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; TUMOR SUPPRESSOR GENE;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CHI-SQUARE DISTRIBUTION; CYCLIN D1; CYCLIN-DEPENDENT KINASE INHIBITOR P16; FEMALE; GENE AMPLIFICATION; GENE DELETION; HEAD AND NECK NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; MIDDLE AGED; PROGNOSIS; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 0036126045     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005537-200203000-00013     Document Type: Article

References (41)

1. Cancer statistics
2. Cell cycle regulators and cancer
3. Loss of heterozygosity on chromosome 9 in human breast cancer: Association with clinical variables and genetic changes at other chromosome regions
4. Inactivation of p53 and amplification of cyclin D1 correlate with clinical outcome in head and neck cancer
5. Amplification of genes within the chromosome 11q13 region is indicative of poor prognosis in patients with operable breast cancer
6. Over expression of cyclin D1 correlates with recurrence in a group of forty-seven operable squamous cell carcinomas of the head and neck
7. Frequent amplification of 11q13 DNA markers is associated with lymph node involvement in human head and neck squamous cell carcinomas
8. Amplification of cyclin D1 in squamous cell carcinoma of the head and neck and the prognostic value of chromosomal abnormalities and cyclin D1 overexpression
9. Oncogenic aberrations of p16INK4/CDKN2 and cyclin D1 cooperate to deregulate G1 control
10. Altered p16/MTS1/CDKN2 and cyclin D1/PRAD-1 gene expression is associated with the prognosis of squamous cell carcinoma of the esophagus
11. Assessment of methods for tissue-based detection of the HER-2/neu alteration in human breast cancer: A direct comparison of fluorescence in situ hybridization and immunohistochemistry
12. Clinical application of fluorescence in situ hybridization for chromosome 11q13 analysis in head and neck cancer
13. Use of FISH to detect chromosomal translocations and deletions
14. Comparison of chromosome aberrations in leiomyoma and leiomyosarcoma using FISH on archival tissue
15. A juvenile polyposis tumor suppressor locus at 10q22 is deleted from nonepithelial cells in the lamin propria
16. Detection of p16 gene deletions in gliomas: A comparison of fluorescence in situ hybridization (FISH) versus quantitative PCR
17. Detection of 11q13 amplification in head and neck cancer using fluorescence in situ hybridization
18. Deletion analysis of the p16/CDKN2 gene in head and neck squamous cell carcinoma tumors by quantitative PCR
19. Dysregulated cyclin D1 expression early in head and neck tumorigenesis: In vivo evidence for an association with subsequent gene amplification
20. Cyclin D1 amplification is independent of p16 inactivation in head and neck squamous cell carcinomas
21. Chromosome 11q13 amplification in head and neck squamous cell carcinoma
22. Heterogeneity of the proliferative fraction and cyclin D1/CCND1 gene amplification in head and neck squamous cell carcinoma
23. Prad-1/Cyclin D1 gene amplification correlates with messenger RNA over expression and tumor progression in human laryngeal carcinomas
24. Frequent amplification of the bcl-1 locus in head and neck squamous cell carcinomas
25. Analysis of gene amplification in head and neck squamous cell carcinomas
26. Cyclin D1 abnormalities and tobacco exposure in head and neck squamous cell carcinoma
27. Chromosome 11q13 amplification in head and neck squamous cell carcinoma
28. Prognostic value of the immunohistochemical detection of p16 expression in nonsmall cell lung carcinoma
29. Higher frequency of alterations in the p16/CDKN1 gene squamous carcinoma lines than in primary tumors of the head and neck
30. Immunohistochemical detection of the cyclin-dependent kinase inhibitor 2/multiple tumor suppressor gene 1 (CDKN2/MTS1) product p16 in archival human solid tumors: Correlation with retinoblastoma protein expression
31. Inverse correlated expression of p16 and Rb protein in non-small cell lung cancers: An immunohistochemical study
32. Rb and p16 expression in resected non-small cell lung tumors
33. MTS1/CDK4I mutations and concomitant loss of heterozygosity at 9p21-23 are frequent events in squamous cell carcinoma of the larynx
34. Differential inactivation of CDKN2 and Rb protein in non-small cell and small-cell lung cancer cell lines
35. Mechanism of inactivation of CDKN2 and MTS2 in non-small cell lung cancer and association with advanced stage
36. High frequency of p16 (CDK2/MTS-1/INK4) inactivation in head and neck squamous cell carcinoma
37. Expression of p16, Rb, and cyclin D1 gene products in oral and laryngeal squamous carcinoma: Biological and clinical implications
38. Potential role for concurrent abnormalities of the cyclin D1, p16CDKN2 and p15CDKN2B genes in certain B cell non-Hodgkin's lymphoma: Functional studies in a cell line (Grant 519)
39. Cyclin D1 and p161NK4A expression predict reduced survival in carcinoma of the anterior tongue
40. Heterogeneity of erbB-2 gene amplification in bladder cancer
41. Thick section fluorescence in situ hybridization on formalin fixed, paraffin-embedded archival tissue provides a histogenetic profile